Skip to content

Author

Yue Li

We have 3 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma

Abstract Background Reliable biomarkers for risk stratification and treatment monitoring in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) treated with first-line chemo-immunotherapy remain limited. This study evaluated the prognostic value of baseline computed tomography (CT)-derived body composition paramete...

Xia Gan, Zheng-Zheng Yu, Ya-Ning Tang et al. · 0 citations
Open access Aug 2026

Comprehensive analysis of SYTL4 differential expression and clinical implications in DLBCL

Findings highlight the potential of SYTL4 as a promising diagnostic marker, prognostic biomarker, and therapeutic target in DLBCL patients and reveal interactions between SYTL4 and key regulators such as phosphatase and actin regulator 2 (PHACTR2), suggesting its potential role in DLBCL progression.

Yue Li, Qi-Qi Zhou · 0 citations
Open access Jul 2026

NSUN2-mediated m5C modification of E2F1 promotes lung adenocarcinoma progression via the RAD54L signaling axis.

This work identifies a hierarchical signaling axis driven by the RNA methyltransferase NSUN2 that fuels LUAD progression and establishes the NSUN2-E2F1-RAD54L axis as a critical driver of LUAD and a promising target for therapeutic intervention.

Yue Li, Chen Chen, Hailin Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.